Scholars Central

Conference abstractPublished 26 Nov 2012

Multidrug resistance proteins 1/4 (ABCC1 /4) confer resistance to arsenic compounds in human myeloid leukemic HL-60 cells

Authors: Naranmandura Hua, Shi Xu, Yan Fang Zhang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

A rsenic trioxide (As 2 O 3 ) is established as one of most effective drugs for treatment of patients with acute promyelocytic leukemia (APL), as well as other types of malignant tumors. However, the non-APL HL-60 cells is resistant to As 2 O 3 , and little is known about the underlying resistance mechanism for As 2 O 3 and its biomethylation products, namely, monomethylarsonous acid (MMA III ) on the treatment of tumors. In the present study, we investigated the molecular mechanisms underlying iAs III and its intermediate metabolite MMA III -induced anticancer effects in the non-APL HL-60 cells. Here, we show that the HL- 60 cells exhibit resistance to inorganic iAs III (IC50=10 μM), but are relatively sensitive to its intermediate MMA III (IC 50 =3.5 μM). Moreover, we found that the multidrug resistance protein 1/4 (MRP1/4), but not MRP2, are expressed in HL-60 cells, which reduced the intracellular arsenic accumulation, and conferred resistance to inorganic iAs III and MMA III . Pretreatment of HL-60 with MK571, an inhibitor of MRP1 and 4, significantly increased iAsIII and MMAIII-induced cytotoxicity and arsenic accumulations, suggesting that the expression of MRP1/4 may lead to HL-60 cells resistance to trivalent arsenic compounds

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Toxicology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Toxicology
  • SubjectToxicology
  • BylineArticles whose byline prints “Naranmandura Hua”
  • BylineArticles whose byline prints “Shi Xu”
  • BylineArticles whose byline prints “Yan Fang Zhang”